Back to company

JJ PHARMA CONSULT ApS: Financial statements 2015

CVR: 33257635

JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -17,398 and a net result of DKK 582,439 compared with DKK 920,163 the year before. Equity amounted to DKK 1,416,253. The solvency ratio was 98.9%.

Gross Profit
-17,398 kr.
Profit/Loss
582,439 kr.
Equity
1,416,253 kr.
Total Assets
1,432,560 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015--17 t.582 t.1.4 mio.-
2014--23 t.920 t.934 t.-
2013--9 t.95 t.183 t.-
2012--6 t.22 t.89 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

JJ PHARMA CONSULT ApS: The 2014 annual report is outApr 14, 2015

JJ PHARMA CONSULT ApS has published its annual report for 2014. Gross profit came to DKK -22,985, and the net result was DKK 920,163.

About JJ PHARMA CONSULT ApS

JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.